Sang-Hyun Kim

9PUBLICATIONS
27CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 04, 2026
Conserved Influenza Epitopes Delivered via MHC-I-Functionalized Nanocarriers Induce Influenza-Specific CTL Responses.

|Jul 08, 2024
Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines.

Sang-Hyun Kim, Erica Españo, Bill Thaddeus Padasas

|May 14, 2023
COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants.

Bill Thaddeus Padasas, Erica Españo, Sang-Hyun Kim

|Nov 16, 2022
Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody.

Sang-Hyun Kim, Ji-Hyun Park, Sun-Jae Lee

|Jan 17, 2022
Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes.

Sang-Hyun Kim, Ha-Eun Park, Seong-Un Jeong

|Jan 11, 2021
Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines.

Chan-Su Park, Sang-Hyun Kim, Chong-Kil Lee

Pageof 2

Frequent Collaborators

6 joint publications

Chan-Su Park

6 joint publications

Chong-Kil Lee

6 joint publications

Jeong-Ki Kim

3 joint publications

Jun-Hyeok Moon